You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Privately held AAX Biotech gains global validation through Daiichi Sankyo agreement
Text:
Tommie Anderberg | [email protected]
The Solna-based biotech company AAX Biotech has entered into a collaboration with Japanese pharmaceutical giant Daiichi Sankyo on its Opti-mAb platform for stabilizing antibodies. BioStock spoke to CEO Maria Lisa Knudsen for...